Bio-ReFine, an Israeli medical device company in the field of interventional structural cardiology, has developed a groundbreaking technology which enables physicians to perform implant-less annuloplasty repair in a simple and safe endovascular procedure.
The Medical Need:
• Millions of patients suffer from mitral or tricuspid valve
regurgitation, a condition that causes blood to leak back into the
heart atriums and reduces the heart’s efficiency.
• Current treatments for valve regurgitation are either invasive
surgery or transcatheter interventions, which have significant
limitations and risks, including: high mortality and morbidity
rates (surgery), implant-related complications, need for lifelong
anti-coagulation medication and anatomical restriction such as
oversized valves (limiting transcatheter implants).
• No viable transcatheter annuloplasty repair technology is
currently available, creating a gap in the available heart valve
repair “toolbox”.
Bio ReFine’s technology offers a unique value proposition for patients and physicians, with the potential of reaching a significant share of the transcatheter valve repair market while supporting the valve replacement market.
-
תעשייה
-
Medical Equipment Manufacturing
-
גודל החברה
-
2-10 עובדים
-
משרדים ראשיים
-
Or Yehuda
-
סוג
-
בבעלות פרטית